Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-067479

Chairman and CEO bought 41,350 shares at an average $1.54 ($63,646)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2021-11-30 Purchase +35,600 $1.51 $53,756 11,080,056 D
Niihara Yutaka Chairman and CEO 2021-12-01 Purchase +5,750 $1.72 $9,890 11,085,806 D
Open-market purchases · 41,350 sh · avg $1.54 · $63,646
Loading xslF345X03/doc4.xml…